arrow
B

Benjamin Maasoumy

Hannover Medical School
H指数:32
被引数:3,805

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort

慢性乙型肝炎核苷 (酸) ide类似物停止后的长期结果-RETRACT-B队列的随访

2026-03-300
OAAI
Neurofilament Light Chains in Serum Predict Post—Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy

血清神经丝轻链可预测经颈静脉肝内门体分流术后肝性脑病

MedComm
IF10.7
2025-11-050
OAAI
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

使用非侵入性检测预测当代多中心队列中cACLD患者的肝功能失代偿

2025-11-040
PRE
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease

基于血液的维也纳3P/5P风险模型可准确预测代偿期晚期慢性肝病患者的首次肝功能失代偿。

2025-10-170
OAAI
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D☆

布勒韦尔肽的治疗反应与慢性丁型肝炎患者门静脉高压的改善相关。

2025-10-170
OAAI
Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy

非肝硬化与肝硬化患者在直接抗病毒治疗前后具有不同的炎症印记

2025-10-010
OAAI
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS

虚弱对接受TIPS置入术的肝硬化患者预后的影响

2025-08-010
OAAI
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis

严重α-1抗胰蛋白酶缺乏症与首次失代偿后并发症风险高于其他肝硬化病因相关。

2025-06-010
OAAI